by investoropportunity | Jan 21, 2023 | Health, Home Page Articles of Insight, Technology
Editas Medicine currently trades at an enterprise value of just $561 million, but its IP portfolio alone is worth billions. This stock traded at over $80/share 2 years ago and is now under $9/share, however the reasons for buying then are just as strong now. It’s...
by investoropportunity | Nov 18, 2022 | Company Research, Health, Home Page Articles of Insight, Technology
Vicarious Surgical Robotic System was added to Time Magazine’s list for the ‘Best Inventions of 2022’ — for reference; Apple’s iPhone was featured by Time in 2007 Best Inventions — NYSE: RBOT has moon-shot potential. Vicarious Surgical...
by investoropportunity | Oct 11, 2022 | Home Page Articles of Insight, Industry & Services, Uncategorized, Utilities Telecom Networks
AWK is a steadily growing cash-cow via regular utility rate increases, new contracts, and annual targeted acquisitions. AWK is also steady dividend payer; today yielding 2% — each year AWK raises the dividends per share, meaning greater compound returns in the...
by investoropportunity | Sep 26, 2022 | Company Research, Energy, Home Page Articles of Insight, Industry & Services, Technology, Uncategorized, Utilities Telecom Networks
NuScale’s VOYGR Power Module which can generate up to 77 MW, the smallest light water reactors in the world. A client can add modules over time as power needs grow. The current market-cap relative to potential market appears undervalued. NuScale Power (SMR)...
by investoropportunity | Sep 23, 2022 | Basic Materials, Company Research, Home Page Articles of Insight, Mining, Uncategorized
Best-of-breed fertilizer stock — Nutrien is looking at sales of ~$40 B this 2022 (43.6% higher than in 2021), profit should excel; in Q2-2022 Nutrien produced nearly as much free cash flow as it did in all of 2021. Looking for exposure to a hot commodity sector...
by investoropportunity | Sep 23, 2022 | Company Research, Home Page Articles of Insight, Industry & Services, Technology
Assuming that by calendar year 2025 Okta will be trading at a valuation multiple of 12 times annual sales, the company will be worth about $50 billion (currently it is ~$8.6B). Then factor in buyout premium on that = quality returns for astute investors establishing a...
Recent Comments